Start for free
Start for free
Sanderling Ventures logo

Sanderling Ventures

North America, California, United States, San Mateo

Description

Sanderling Ventures is an investment firm that works on building and funding new biomedical companies.

Investor Profile

Sanderling Ventures has made 95 investments, with 0 in the past 12 months and 24% as lead.

Stage Focus

  • Series C (23%)
  • Series B (21%)
  • Series A (20%)
  • Series D (15%)
  • Series Unknown (12%)
  • Debt Financing (3%)
  • Series E (3%)
  • Post Ipo Equity (1%)
  • Series F (1%)
  • Seed (1%)

Country Focus

  • United States (92%)
  • Canada (7%)
  • India (1%)

Industry Focus

  • Health Care
  • Biotechnology
  • Pharmaceutical
  • Medical
  • Medical Device
  • Therapeutics
  • Information Technology
  • Life Science
  • Genetics
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sanderling Ventures frequently co-invest with?

Qualcomm Ventures
Qualcomm Ventures
North America, California, United States, San Diego
Co-Investments: 5
MV
Mesa Verde Venture Partners
North America, California, United States, San Diego
Co-Investments: 7
PrairieGold Venture Partners
PrairieGold Venture Partners
North America, South Dakota, United States, Sioux Falls
Co-Investments: 4
Alta Partners
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 9
WH
West Health Investment Fund
North America, California, United States, La Jolla
Co-Investments: 3
Thomas, McNerney & Partners
Thomas, McNerney & Partners
North America, Connecticut, United States, Stamford
Co-Investments: 4
Mayo Clinic Ventures
Mayo Clinic Ventures
North America, Minnesota, United States, Rochester
Co-Investments: 6
Clarus Ventures
Clarus Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 5
Asset Management Ventures (AMV)
Asset Management Ventures (AMV)
North America, California, United States, Palo Alto
Co-Investments: 6
Intel Capital
Intel Capital
North America, California, United States, Santa Clara
Co-Investments: 5

Which angels does Sanderling Ventures often collaborate with?

JH
Shared Deals: 1
SH
Scott Harkonen
North America, California, United States
Shared Deals: 1
André Desmarais
Shared Deals: 1
MK
Shared Deals: 1
RJ
Shared Deals: 1
John P. Cooke
Shared Deals: 1
JD
Shared Deals: 1

What are some of recent deals done by Sanderling Ventures?

CalciMedica

La Jolla, California, United States

CalciMedica is engaged in the discovery and development of small molecule drugs for the treatment of inflammatory and autoimmune disorders.

Health CareInformation TechnologyLife Science
Post Ipo EquityJan 22, 2024
Amount Raised: $55,000,000
Glycomine

San Francisco, California, United States

Glycomine is an early-stage biotech working on replacement therapies for rare diseases.

BiotechnologyPharmaceuticalTherapeutics
Series BJun 23, 2021
Amount Raised: $35,000,000
CalciMedica

La Jolla, California, United States

CalciMedica is engaged in the discovery and development of small molecule drugs for the treatment of inflammatory and autoimmune disorders.

Health CareInformation TechnologyLife Science
Series DMar 11, 2021
Amount Raised: $21,000,000
CalciMedica

La Jolla, California, United States

CalciMedica is engaged in the discovery and development of small molecule drugs for the treatment of inflammatory and autoimmune disorders.

Health CareInformation TechnologyLife Science
Series CMay 22, 2020
Amount Raised: $15,000,000
ViaCyte

San Diego, California, United States

ViaCyte is a preclinical therapeutic company specializing in regenerative medicine therapies for diabetes.

BiotechnologyDiabetesHealth CareMedicalTherapeutics
Series DMar 20, 2020
Amount Raised: $32,645,780
Glycomine

San Francisco, California, United States

Glycomine is an early-stage biotech working on replacement therapies for rare diseases.

BiotechnologyPharmaceuticalTherapeutics
Series BAug 7, 2019
Amount Raised: $33,000,000
ViaCyte

San Diego, California, United States

ViaCyte is a preclinical therapeutic company specializing in regenerative medicine therapies for diabetes.

BiotechnologyDiabetesHealth CareMedicalTherapeutics
Series DNov 29, 2018
Amount Raised: $80,000,000
Metavention

Eden Prairie, Minnesota, United States

Metavention develops medical devices to help with interventional therapies for high blood pressure and other metabolic diseases.

BiotechnologyDiabetesHealth Care
Series CJan 8, 2018
Amount Raised: $65,000,000
SpecificiT Pharma

Montréal, Quebec, Canada

A privately held biopharmaceutical company.

BiotechnologyHealth CarePharmaceutical
SeedSep 11, 2017
PreciThera

Montréal, Quebec, Canada

PreciThera is a biotechnology company

BiotechnologyPharmaceuticalTherapeutics
Series AJul 27, 2017
Amount Raised: $28,709,691
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator